triple-negative breast cancer

Open Access
Disparities in Palliative Care Utilization in Metastatic Triple-negative Breast Cancer: A National Cancer Database Study
CHER YING FOO, OJASAV SEHRAWAT, AKSHJOT PURI, WAQAR HAQUE and BIN S. TEH

Anticancer Research August 2026, 46 (8) 4385-4392; DOI: https://doi.org/10.21873/anticanres.18295
Open Access
Immunohistochemical Evaluation of Tumor Characteristic Retention in Triple-negative Breast Cancer PDOX Models
SHOTARO INOUE, MAYUKO MIKI, SACHIKO MIZUMOTO, MAYUKO YAMAMOTO, MOTOI BABA, HIROKAZU TANINO, TOMONARI KUNIHISA and SACHIKO INUBUSHI

Anticancer Research October 2025, 45 (10) 4169-4180; DOI: https://doi.org/10.21873/anticanres.17769
You have access
Combined Biomarkers for Prediction of Immune Checkpoint Inhibitor Response in Patients With Triple-negative Breast Cancer
HAN GYEOL KIM, SO YOUNG KANG, KYOUNG-MEE KIM, JI-YEON KIM, YEON HEE PARK, JIN SEOK AHN, YOUNG-HYUCK IM, YOOJOO LIM, SANGHOON SONG, KYUNGHYUN PAENG and EUN YOON CHO

Anticancer Research June 2025, 45 (6) 2575-2586; DOI: https://doi.org/10.21873/anticanres.17629
Open Access
Combination of Recombinant Methioninase With Rapamycin or Chloroquine Is Synergistic to Highly Inhibit Triple-negative Breast Cancer Cells In Vitro
JINSOO KIM, QINGHONG HAN, BYUNG MO KANG, KOHEI MIZUTA, YOHEI ASANO, MICHAEL BOUVET and ROBERT M. HOFFMAN

Anticancer Research May 2025, 45 (5) 1853-1859; DOI: https://doi.org/10.21873/anticanres.17564
You have access
Male Breast Cancer: A Single Institutional Clinicopathological Profiling
SHUBHA DE SARKAR, SOIRINDHRI BANERJEE, AYDEN ISMAIL, AVENIE MAVADIA, SUNYOUNG CHOI, ARUNI GHOSE and STERGIOS BOUSSIOS

Anticancer Research March 2025, 45 (3) 1097-1104; DOI: https://doi.org/10.21873/anticanres.17497
You have access
Clinical Significance of FAM83G in Breast Cancer: Association With Triple-negative Subtype and Prognosis
TAKAKO IKEDA, CHIKAKO KANNO HONDA, SASAGU KUROZUMI, TAKEHIKO YOKOBORI, AYAKA KATAYAMA, KEI MASUDA, TETSUNARI OYAMA, KYOICHI KAIRA, JUN HORIGUCHI, KEN SHIRABE and TAKAAKI FUJII

Anticancer Research November 2024, 44 (11) 4877-4883; DOI: https://doi.org/10.21873/anticanres.17313
You have access
CD47 and Calreticulin Expression in Breast Cancer Subtypes and Anti-CD47 Inhibitory Effects in Macrophage-mediated Phagocytosis
JUTHAMARD CHANTARAAMPORN, PHATTARIN POTHIPAN, TITIPATIMA SAKULTERDKIAT, BURANA KHIANKAEW, LALITA LUMKUL, PHOTSATHORN MUTAPAT, PHICHAMON PHETCHAHWANG, JISNUSON SVASTI and VORARATT CHAMPATTANACHAI

Anticancer Research November 2024, 44 (11) 4929-4940; DOI: https://doi.org/10.21873/anticanres.17318
Open Access
Comparison of the Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumor-infiltrating Lymphocytes in Triple-negative Breast Cancer: Preliminary Results of the PERCEPTION Study
ALEXIA GIRO, JUDITH PASSILDAS-JAHANMOHAN, MYRIAM KOSSAI, YANNICK BIDET, IOANA MOLNAR, MAUREEN BERNADACH, FREDERIQUE PENAULT-LLORCA, CATHERINE ABRIAL, XAVIER DURANDO and NINA RADOSEVIC-ROBIN

Anticancer Research November 2024, 44 (11) 4983-4994; DOI: https://doi.org/10.21873/anticanres.17323
You have access
CD8-Positive T-Cells Are Key Immune Cells for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
NATSUKI UENAKA, EIICHI SATO, YOSHIYA HORIMOTO, SAORI KAWAI, MARIKO ASAOKA, HIROSHI KAISE, KIMITO YAMADA and TAKASHI ISHIKAWA

Anticancer Research October 2024, 44 (10) 4525-4536; DOI: https://doi.org/10.21873/anticanres.17281
You have access
Association Between High Expression of Phosphorylated-STMN1 and Mesenchymal Marker Expression and Cancer Stemness in Breast Cancer
TADASHI HANDA, TAKEHIKO YOKOBORI, SAYAKA OBAYASHI, TAKAAKI FUJII, KEN SHIRABE and TETSUNARI OYAMA

Anticancer Research December 2023, 43 (12) 5341-5348; DOI: https://doi.org/10.21873/anticanres.16737

Main menu

User menu

Search

triple-negative breast cancer

Pages